Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.
about
Advanced vaccine candidates for Lassa feverProgress in the experimental therapy of severe arenaviral infectionsA live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus.LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.Pathogenesis of arenavirus hemorrhagic fevers.Multifunctional nature of the arenavirus RING finger protein Z.Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidateNovel mechanism of arenavirus-induced liver pathology.Lassa virus.Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitroThe search for animal models for Lassa fever vaccine developmentAn attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.Macaque models of human infectious disease.Fibroblastic reticular cells and their role in viral hemorrhagic fevers.Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Host cell factors as antiviral targets in arenavirus infection.Animal models, prophylaxis, and therapeutics for arenavirus infections.Immune responses and Lassa virus infection.Vaccine platforms to control Lassa fever.Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticlesEarly blood profiles of virus infection in a monkey model for Lassa fever.Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus.Gene expression in primate liver during viral hemorrhagic fever.A Primate Model for Viral Hemorrhagic Fever.Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for use with Infected Organ Transplant Recipients.
P2860
Q26823627-CB74C2D1-C349-4BAA-BAD9-1EE44B2F3BF4Q27024953-7A4A1B24-5616-4600-AF34-310CA64AAA47Q33226128-A5174CD2-4C42-4EA1-869D-B54F714C13C7Q33383772-A54F8E58-5637-4B3A-B179-9CCA2CF85886Q33781829-A66912B7-8248-4D7B-9405-BB0F05DD2760Q34338137-5B084EA5-C473-44B2-83EE-D52985F769EAQ34467311-CABFB4C1-AD67-4FD5-8489-79BBFA07363DQ34625899-0EC52580-B9CD-41B9-983C-114AC33882A8Q34645925-61BDDCE0-4D72-49A3-AB23-634B12E90AF3Q34999818-F651DF05-8024-457F-9E93-8AAB9421812AQ35230745-7D1DE831-EA6D-45A4-AC83-9842196C040FQ35919691-3225D06D-C879-40BB-AF58-EE95792A8550Q36155495-2194165B-8532-4288-A5FE-D2B395AD241AQ36588064-B79D3F8D-E237-4A0E-9715-B98E2495DB0EQ36698306-52C3D977-9719-41C8-8C41-E946BBE7B291Q36925354-B2DE6581-23DA-4A8C-94D9-DBED29BD1C11Q36970552-38709DC1-65B5-48FD-9427-4CCFDC9BDE44Q37103536-C866DA12-A98D-4A70-A15A-57D56A0A78E7Q37463214-47B7CAF5-C9CA-4DAF-BB75-A44A9417FE6FQ37912497-95FCAC75-F7BB-4788-BAAE-8670618FA9D3Q38061425-22E138BD-548F-49A3-9E34-96A38BBE24B8Q38061427-CF842605-8B7B-43A7-9AEE-478EC4889E97Q38064284-94B7B304-06AF-4DC6-874A-3C39AE9A32DFQ38823264-353C7197-D392-46A1-9C54-CAA5ABD057FCQ39893565-53891E5D-E83D-4EF9-AB43-64B9B9DFBCD5Q40210245-3EF9F88E-1107-4723-98BA-E58112A20014Q40381119-24A76CBF-6DBA-4BF4-86A1-E9106B4EFDA9Q40397175-7FBDC5C3-4CB5-4D2F-9475-3BE7EE7FE958Q41922365-A56522AA-3EDB-4541-AA74-BAE7D2D605D5Q50034248-EE395489-8AD5-440E-A477-906A8E7222E8Q54211351-0B61A6AE-28CF-4AE9-B202-4499BB31A046
P2860
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@ast
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@en
type
label
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@ast
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@en
prefLabel
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@ast
Hemorrhagic fever occurs after ...... ocytic choriomeningitis virus.
@en
P2093
P2860
P356
P1476
Hemorrhagic fever occurs after ...... hocytic choriomeningitis virus
@en
P2093
Amy Usborne
Carol Emerson
Igor S Lukashevich
Jacque Mitchen
Juan D Rodas
Mahmoud Djavani
Maria S Salvato
P2860
P304
P356
10.1002/JMV.2206
P577
2002-06-01T00:00:00Z